Table 1.
Unadjusted and adjusted Hazard Ratio (HR) from Cox proportional hazards modeling for length-of-stay in the AgeBru cohort (N = 224).
Unadjusted model |
Adjusted model 1 |
Adjusted model 2 |
||||
---|---|---|---|---|---|---|
HR [95% CI] | P-value | HR [95% CI] | P-value | HR [95% CI] | P-value | |
GNRI at high risk (≤98) | 0.90 [0.68–1.19] | 0.454 | 0.93 [0.70–1.24] | 0.623 | 0.97 [0.72–1.32] | 0.847 |
Each additional year of age | 0.99 [0.97–1.00] | 0.030 | 0.98 [0.96–1.00] | 0.022 | 0.97 [0.95–0.99] | 0.014 |
Being of female sex | 0.94 [0.72–1.22] | 0.632 | 0.93 [0.70–1.22] | 0.599 | 0.91 [0.68–1.20] | 0.497 |
Being cohabiting with partner | 0.81 [0.622–1.06] | 0.124 | 0.91 [0.68–1.21] | 0.516 | 0.91 [0.68–1.21] | 0.509 |
Each additional point on Katz index | 0.97 [0.94–1.00] | 0.069 | – | – | ||
Each additional point of CRP | 1.00 [1.00–1.00] | 0.968 | – | 0.99 [1.00–1.00] | 0.354 | |
Each additional point of BMI | 1.02 [1.00–1.05] | 0.036 | – | – | ||
History of hypertension | 0.88 [0.63–1.23] | 0.464 | 1.04 [0.71–1.52] | 0.826 | 1.06 [0.73–1.55] | 0.754 |
History of diabetes mellitus | 1.06 [0.80–1.38] | 0.685 | 0.92 [0.69–1.21] | 0.542 | 0.92 [0.70–1.22] | 0.585 |
History of cardiopathy | 0.76 [0.58–0.99] | 0.040 | 0.82 [0.60–1.12] | 0.215 | 0.81 [0.59–1.10] | 0.183 |
History of chronic respiratory disease | 0.94 [0.69–1.27] | 0.677 | 0.88 [0.63–1.22] | 0.433 | 0.90 [0.64–1.25] | 0.527 |
History of cognitive impairment | 0.60 [0.45–0.80] | 0.000 | – | – | ||
History of cancer | 0.71 [0.53–0.96] | 0.027 | 0.68 [0.49–0.94] | 0.019 | 0.67 [0.48–0.93] | 0.015 |
BMI: body mass index; CI: confidence interval; CRP: C-reactive protein; GNRI: Geriatric Nutritional Risk Index. Two groups of patients were defined according to the risk level: Patients at high risk (GNRI ≤98) and patients at low risk (GNRI >98). Adjusted model 1: Age, sex, cohabiting with partner, hypertension, diabetes mellitus, cardiopathy, chronic respiratory disease, and cancer were used as adjusting variables. Adjusted model 2: Same model 1 with the C-reactive protein (CRP) as added adjusting variable.